| 3.41 Data as of May 24 |  +0.17 / +5.25%Today’s Change | 2.06 Today|||52-Week Range 4.79 | +40.91% Year-to-Date |
| Previous close | 3.24 |
| Today’s open | 3.25 |
| Day’s range | 3.20 - 3.41 |
| Volume | 10,499 |
| Average volume (3 months) | 45,490 |
| Market cap | $60.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +200.00% |
| Earnings growth (this year) | +233.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +8.89% |
| P/E ratio | 113.7 |
| Price/Sales | 1.54 |
| Price/Book | 2.63 |
| Today’s change | Today’s % change | |
|---|---|---|
| TGXTheragenics Corp | +0.01 | +0.25% |
| TSONTranS1 Inc | +0.23 | +12.04% |
| MRICMRI Interventions In... | 0.00 | 0.00% |
| MELAMELA Sciences Inc | -0.01 | -0.90% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $27.7M |
| Annual profit (last year) | $617.0K |
| Net profit margin | 2.23% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Andrew Makrides |
President, Director & Chief Marketing Officer J. Robert Saron |
Corporate headquarters Melville, New York |
.
